Rx Spending Continues To Lag Overall Health Growth; New Drugs Have Positive Impact in 2011 Data
This article was originally published in RPM Report
Executive Summary
Prescription drug spending modestly increased in 2011 but continues to lag historically slow rates of overall health spending growth. But it could have been worse: government actuaries cite spending on new brands as driving what growth there is.